Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1951 1
1954 1
1962 1
1964 1
1966 2
1967 1
1968 1
1971 1
1976 2
1977 3
1980 2
1981 2
1983 2
1984 3
1987 1
1990 2
1991 5
1993 3
1994 4
1995 8
1996 7
1997 10
1998 8
1999 5
2000 2
2001 8
2002 2
2003 3
2004 5
2005 5
2006 2
2007 3
2008 5
2009 8
2010 6
2011 15
2012 4
2013 12
2014 12
2015 19
2016 22
2017 20
2018 20
2019 26
2020 25
2021 30
2022 23
2023 33
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Results by year

Filters applied: . Clear all
Page 1
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.
Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, Chau J, Eder L, Fernández-Ávila DG, FitzGerald O, Garg A, Gladman DD, Goel N, Helliwell PS, Husni ME, Jadon DR, Katz A, Laheru D, Latella J, Leung YY, Lindsay C, Lubrano E, Mazzuoccolo LD, Mease PJ, O'Sullivan D, Ogdie A, Olsder W, Palominos PE, Schick L, Steinkoenig I, de Wit M, van der Windt DA, Kavanaugh A; GRAPPA Treatment Recommendations domain subcommittees. Coates LC, et al. Among authors: lindsay c. Nat Rev Rheumatol. 2022 Aug;18(8):465-479. doi: 10.1038/s41584-022-00798-0. Epub 2022 Jun 27. Nat Rev Rheumatol. 2022. PMID: 35761070 Free PMC article. Review.
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial.
de Langen AJ, Johnson ML, Mazieres J, Dingemans AC, Mountzios G, Pless M, Wolf J, Schuler M, Lena H, Skoulidis F, Yoneshima Y, Kim SW, Linardou H, Novello S, van der Wekken AJ, Chen Y, Peters S, Felip E, Solomon BJ, Ramalingam SS, Dooms C, Lindsay CR, Ferreira CG, Blais N, Obiozor CC, Wang Y, Mehta B, Varrieur T, Ngarmchamnanrith G, Stollenwerk B, Waterhouse D, Paz-Ares L; CodeBreaK 200 Investigators. de Langen AJ, et al. Among authors: lindsay cr. Lancet. 2023 Mar 4;401(10378):733-746. doi: 10.1016/S0140-6736(23)00221-0. Epub 2023 Feb 7. Lancet. 2023. PMID: 36764316 Clinical Trial.
Mechanisms of Resistance to KRASG12C Inhibitors.
Dunnett-Kane V, Nicola P, Blackhall F, Lindsay C. Dunnett-Kane V, et al. Among authors: lindsay c. Cancers (Basel). 2021 Jan 5;13(1):151. doi: 10.3390/cancers13010151. Cancers (Basel). 2021. PMID: 33466360 Free PMC article. Review.
The evolution of non-small cell lung cancer metastases in TRACERx.
Al Bakir M, Huebner A, Martínez-Ruiz C, Grigoriadis K, Watkins TBK, Pich O, Moore DA, Veeriah S, Ward S, Laycock J, Johnson D, Rowan A, Razaq M, Akther M, Naceur-Lombardelli C, Prymas P, Toncheva A, Hessey S, Dietzen M, Colliver E, Frankell AM, Bunkum A, Lim EL, Karasaki T, Abbosh C, Hiley CT, Hill MS, Cook DE, Wilson GA, Salgado R, Nye E, Stone RK, Fennell DA, Price G, Kerr KM, Naidu B, Middleton G, Summers Y, Lindsay CR, Blackhall FH, Cave J, Blyth KG, Nair A, Ahmed A, Taylor MN, Procter AJ, Falzon M, Lawrence D, Navani N, Thakrar RM, Janes SM, Papadatos-Pastos D, Forster MD, Lee SM, Ahmad T, Quezada SA, Peggs KS, Van Loo P, Dive C, Hackshaw A, Birkbak NJ, Zaccaria S; TRACERx Consortium; Jamal-Hanjani M, McGranahan N, Swanton C. Al Bakir M, et al. Among authors: lindsay cr. Nature. 2023 Apr;616(7957):534-542. doi: 10.1038/s41586-023-05729-x. Epub 2023 Apr 12. Nature. 2023. PMID: 37046095 Free PMC article.
Prediabetes and skeletal health.
Lindsay C, Shieh A. Lindsay C, et al. Curr Opin Endocrinol Diabetes Obes. 2023 Aug 1;30(4):200-205. doi: 10.1097/MED.0000000000000812. Epub 2023 May 29. Curr Opin Endocrinol Diabetes Obes. 2023. PMID: 37248797 Review.
Direct Ras G12C inhibitors: crossing the rubicon.
Lindsay CR, Blackhall FH. Lindsay CR, et al. Br J Cancer. 2019 Jul;121(3):197-198. doi: 10.1038/s41416-019-0499-1. Epub 2019 Jun 26. Br J Cancer. 2019. PMID: 31239544 Free PMC article.
KRAS: Reasons for optimism in lung cancer.
Lindsay CR, Jamal-Hanjani M, Forster M, Blackhall F. Lindsay CR, et al. Eur J Cancer. 2018 Aug;99:20-27. doi: 10.1016/j.ejca.2018.05.001. Epub 2018 Jun 9. Eur J Cancer. 2018. PMID: 29894909 Review.
356 results